REVVITY, INC Depreciation
REVVITY, INC (RVTY) reported Depreciation of $17.17 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- REVVITY, INC depreciation for the quarter ending 2026-07-05 was $17.17M, a 1.85% decline year-over-year.
- REVVITY, INC depreciation for the quarter ending 2026-04-05 was $19.98M, a 35.68% increase year-over-year.
- REVVITY, INC depreciation for the quarter ending 2025-12-28 was $19.56M, a 13.99% increase year-over-year.
- REVVITY, INC depreciation for the quarter ending 2025-09-28 was $17.98M, a 0.24% decline year-over-year.
- REVVITY, INC depreciation for fiscal 2025 was $69.75M, a 1.87% increase from fiscal 2024.
- REVVITY, INC depreciation for fiscal 2024 was $68.47M, a 2.73% increase from fiscal 2023.
- REVVITY, INC depreciation for fiscal 2023 was $66.66M, a 18.26% increase from fiscal 2023.
- REVVITY, INC depreciation for fiscal 2023 was $56.36M, a 2.66% increase from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-07-05 | $17.17M 10-Q · filed 2026-08-11 | $37.14M 10-Q · filed 2026-08-11 | $56.70M derived: sum of 3 quarters · filed 2026-08-11 | $74.69M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-04-05 | $19.98M 10-Q · filed 2026-05-12 | $39.53M derived: sum of 2 quarters · filed 2026-05-12 | $57.52M derived: sum of 3 quarters · filed 2026-05-12 | $75.01M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-28 | $19.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $37.54M derived: sum of 2 quarters · filed 2026-02-24 | $55.03M derived: sum of 3 quarters · filed 2026-08-11 | $69.75M 10-K · filed 2026-02-24 | |
| 2025-09-28 | $17.98M 10-Q · filed 2025-11-04 | $35.48M derived: sum of 2 quarters · filed 2026-08-11 | $50.20M 10-Q · filed 2025-11-04 | $67.36M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-29 | $17.49M 10-Q · filed 2026-08-11 | $32.21M 10-Q · filed 2026-08-11 | $49.37M derived: sum of 3 quarters · filed 2026-08-11 | $67.40M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-30 | $14.72M 10-Q · filed 2026-05-12 | $31.88M derived: sum of 2 quarters · filed 2026-05-12 | $49.91M derived: sum of 3 quarters · filed 2026-05-12 | $66.63M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-29 | $17.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $35.19M derived: sum of 2 quarters · filed 2026-02-24 | $51.91M derived: sum of 3 quarters · filed 2026-02-24 | $68.47M 10-K · filed 2026-02-24 | |
| 2024-09-29 | $18.03M 10-Q · filed 2025-11-04 | $34.75M derived: sum of 2 quarters · filed 2025-11-04 | $51.32M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $16.72M 10-Q · filed 2025-08-05 | $33.29M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | $16.56M 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $66.66M 10-K · filed 2026-02-24 | $66.70M 10-K · filed 2024-02-27 | |||
| 2023-01-01 | $56.36M 10-K · filed 2025-02-25 | $56.40M 10-K · filed 2023-03-01 | |||
| 2022-01-02 | $54.90M 10-K · filed 2024-02-27 | $67.30M 10-K · filed 2022-03-03 | |||
| 2021-01-03 | $40.70M 10-K · filed 2023-03-01 | $54.00M 10-K · filed 2021-03-02 | |||
| 2019-12-29 | $49.70M 10-K · filed 2022-03-03 | ||||
| 2018-12-30 | $44.70M 10-K · filed 2021-03-02 | ||||
| 2017-12-31 | $31.30M 10-K · filed 2020-02-25 | ||||
| 2017-01-01 | $28.50M 10-K · filed 2019-02-26 | ||||
| 2016-01-03 | $28.70M 10-K · filed 2018-02-27 | $33.40M 10-K · filed 2016-03-01 | |||
| 2014-12-28 | $29.00M 10-K · filed 2017-02-28 | $33.30M 10-K · filed 2015-02-24 | |||
| 2013-12-29 | $37.60M 10-K · filed 2016-03-01 | $38.10M 10-K · filed 2014-02-25 | |||
| 2012-12-30 | $35.00M 10-K · filed 2015-02-24 | $35.60M 10-K · filed 2013-02-26 | |||
| 2012-01-01 | $30.90M 10-K · filed 2014-02-25 | ||||
| 2011-01-02 | $28.40M 10-K · filed 2013-02-26 | ||||
| 2010-01-03 | $26.60M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |